Upgrade to SI Premium - Free Trial

Galectin Therapeutics (GALT)

4.61 +0.26 (5.98%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update  August 14, 2026 8:00 AM - Globe NewsWire Form 8-K GALECTIN THERAPEUTICS For: Aug 14 August 14, 2026 7:56 AM - SEC Filing Form 10-Q GALECTIN THERAPEUTICS For: Jun 30 August 14, 2026 7:51 AM - SEC Filing Form SCHEDULE 13D/A GALECTIN THERAPEUTICS Filed by: Uihlein Richard E August 4, 2026 8:30 AM - SEC Filing Galectin Therapeutics converts $105.8M in debt to equity August 4, 2026 8:04 AM - StreetInsider Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet August 4, 2026 8:00 AM - Globe NewsWire Form 4 GALECTIN THERAPEUTICS For: Jul 31 Filed by: Uihlein Richard E August 4, 2026 7:52 AM - SEC Filing Form 8-K GALECTIN THERAPEUTICS For: Jul 31 August 4, 2026 7:50 AM - SEC Filing Form 4 GALECTIN THERAPEUTICS For: Jul 14 Filed by: Jamil Khurram July 16, 2026 5:40 PM - SEC Filing Form 4 GALECTIN THERAPEUTICS For: Jun 26 Filed by: Shlevin Harold H. June 30, 2026 7:24 PM - SEC Filing Form 4 GALECTIN THERAPEUTICS For: Jun 26 Filed by: Jamil Khurram June 30, 2026 7:23 PM - SEC Filing Form 144 GALECTIN THERAPEUTICS Filed by: Shlevin Harold H. June 29, 2026 4:10 PM - SEC Filing Form 144 GALECTIN THERAPEUTICS Filed by: Jamil Khurram June 26, 2026 6:09 PM - SEC Filing Form 144 GALECTIN THERAPEUTICS Filed by: Shlevin Harold H. June 26, 2026 4:16 PM - SEC Filing Form 4 GALECTIN THERAPEUTICS For: Jun 23 Filed by: Jamil Khurram June 25, 2026 4:06 PM - SEC Filing Form 144 GALECTIN THERAPEUTICS Filed by: Jamil Khurram June 23, 2026 4:15 PM - SEC Filing Galectin reaches FDA agreement on belapectin Phase 3 trial design June 23, 2026 8:00 AM - StreetInsider Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension June 23, 2026 8:00 AM - Globe NewsWire Form 8-K GALECTIN THERAPEUTICS For: Jun 23 June 23, 2026 7:51 AM - SEC Filing Full Article List